🔎 Trials Near Me

Pradžia › Ewingo sarkoma › Ohio

Ewingo sarkoma klinikiniai tyrimai Ohio

8 tyrimai dėl Ewingo sarkoma ieško dalyvių vietose Ohio.

Miestai Ohio

Oficialus tyrimo tekstas (anglų kalba)

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

  • Cleveland Clinic Children's, Cleveland
  • Nationwide Children's Hospital, Columbus
Renkami dalyviai1 fazė
Amžius 1 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07194044

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Renkami dalyviai1 fazė
Amžius nuo 12 iki 85 · Visoms lytims · Atnaujinta 2026-09-08 · NCT03715933

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Renkami dalyviai1/2 fazė
12 Months – 30 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT04851119

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

  • Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-06 · NCT05210374

Single Arm Romiplostim to Prevent CIT

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius 1 ir vyresni · Visoms lytims · Atnaujinta 2026-03-18 · NCT07048249

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

  • The Ohio State University Wexner Medical Center, Columbus
Renkami dalyviai
Amžius 13 ir vyresni · Visoms lytims · Atnaujinta 2026-02-06 · NCT06387485

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
Renkami dalyviai1/2 fazė
Amžius nuo 2 iki 30 · Visoms lytims · Atnaujinta 2026-02-03 · NCT05734066

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Nationwide Children's Hospital, Columbus
Renkami dalyviai2 fazė
18 Months – 40 Years · Visoms lytims · Atnaujinta 2025-08-12 · NCT05135975

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.